Access is everything.
With HCA, you tap into an expert network of care. From conducting large-scale clinical research with partners including Harvard Pilgrim Institute and the CDC, to using data from more than 37 million patient encounters each year, HCA Healthcare is driven to help physicians discover and deliver predictive, precise and personalized medicine for their patients.
Powerful partners
Just as we partner with physicians to champion health, HCA Healthcare partners with the brightest and the best to help improve medical practices and patient care. HCA Healthcare founded a not-for-profit research institute Partnership for Advancing Clinical Excellence (PACE) which collaborates with academic institutions and funding agencies to advance medical knowledge and improve patient care through large-scale clinical research.
Creating a new standard of care
As a learning health system, we develop and share best practices across our enterprise that help continuously improve patient care, using evidence-based guidance, tools, measurement, advanced analytics and data science to support safe, effective, compassionate care.
More than 40 HCA Healthcare hospitals and 75,000 patients took part in an 18-month study to determine the best care approach to preventing MRSA infections in ICUs. The study, called REDUCE MRSA, found using antimicrobial soap and a nasal ointment on adult ICU patients reduces bloodstream infections, including MRSA, by 44 percent. The findings led to the creation of a new model of care, called universal decolonization, which all HCA Healthcare hospitals adopted in 2013.
Following its publication in the New England Journal of Medicine, the REDUCE MRSA’s findings have gone on to set new standards in infection prevention across the country.
Big data answers big questions
As physicians, we depend on and benefit from patient care data in order to inform and improve future treatment. At HCA, we are fortunate to have access to data across 182 hospitals and 37 million patient encounters a year.
Life-changing discoveries
Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated treatments and advanced cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
In 2022, Sarah Cannon Research Institute (SCRI) formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. The combined research network brings together 1,300+ physicians who are providing access to cutting-edge research at more than 250 locations in 26 states across the U.S.
